Our Strategic Partners

We’ve been fortunate enough to surround ourselves with outstanding partners in all aspects of healthcare, life sciences, and finance. We continue to utilize these partnerships to broaden our network and our reach. 

The MedTech Conference is the leading gathering in North America of global MedTech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, and other key responsibilities. Along with industry leaders, the international conference attracts business development professionals, investors, policymakers, members of the media, legal experts, consultants, distributors, and other important stakeholders.

More than 2,500 attendees will network, conduct business, gain access to capital, and share insights in San Diego from October 5-7. The conference also features world-class plenary speakers, networking and business development opportunities.


Brooks, Houghton & Company, Inc. (“BHC”) is a merchant-banking firm located in New York that focuses on debt and equity financing, strategic advisory and M&A and direct investing utilizing dedicated investment funds. The firm’s broker-dealer, Brooks, Houghton Securities, Inc., is a FINRA and SIPC member.


Tiberend Strategic Advisors, Inc. (TSAI) is a full service investor and corporate communications firm specializing in the healthcare and life sciences industry. Founded in 1989, TSAI’s mission is to provide expert public and investor relations counsel to companies along the entire development lifecycle, from emerging, clinical-stage to publicly traded, revenue generating. In doing so, TSAI creates individualized platforms for companies to communicate their value proposition to those audiences that have the greatest influence on their growth and success – investors, industry stakeholders, customers and the media.



KPMG LLP, the audit, tax and advisory firm, is the U.S. member firm of KPMG International Cooperative (“KPMG International”). KPMG International’s member firms have 162,000 professionals, including more than 9,000 partners, in 155 countries.


For more than 50 years, Wilson Sonsini Goodrich & Rosati has offered a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. With deep roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin; Beijing; Brussels; Hong Kong; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE.


The core business of Legend Capital is early-stage Venture Capital and expansion-stage Growth Capital investment. Legend Capital is now managing six USD funds and three RMB funds, with AUM over RMB20 billion, and focuses on innovation and growth enterprises with operations in China or related to China. By the end of 2014, Legend Capital had invested in over 200 companies, of which 30 are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange, GEM and ChiNext of Shenzhen Stock Exchange, and another 19 companies achieved exit through M&A. Legend Capital has an investment team with over 50 professionals, including 23 partners.

With the vision of “becoming one of the most valuable and most respected investment companies with international influence” and through driving the innovation and growth of business enterprises through capital and management support, Legend Capital plays an active role in promoting industry advancement and social development, and strives for creating dream business and sharing success with partners of shared vision and goals.


Founded in 2014, LenoMed is a Chinese medical device platform company co-invested by Legend Capital and Legend Star to undertake technology transfer from overseas licensing or cross border investments and to provide services including product registration at CFDA, business management, marketing & sales, investment and joint venture arrangement, merger and acquisition. LenoMed currently focuses on the diabetes, cardiovascular and neuro-stimulation areas.


BioBAY is located in Dushu Lake Higher Education Town of Suzhou Industrial Park (SIP). Suzhou Industrial Park (SIP), the most important cooperation program between China and Singapore, is committed to building a globally competitive high-tech industrial park. More than 400 high-tech innovative companies covering drug discovery, medical devices (including IVD), biotech, CRO and nanotech have been located in BioBAY, as well as Cold Spring Harbor Asia Conference Center, and 8000 scientists and professionals have come to join this dynamic innovative community.


Legend Star was founded in 2008 as an incubator project and designed to capture opportunities for startup technology companies. Legend Star aims to assist in funding, training, recruiting, and providing other resources used to promote startup companies, their concepts, and their technologies. In addition, Legend Star has also the longest history in running an exclusive, invite-only entrepreneurial training course for the CEOs of startups and growth stage Chinese companies.


Founded in 2010, Beijing Bio-welcome Consulting CO., LTD is located in Yizhuang Economic and Technological Development Zone and functions as a high-technology enterprise in Beijing. Bio-welcome is committed to providing quality resources for domestic and foreign pharmaceutical companies, including new drug development, drug registration, drug clinical research, and many other services. Beijing Bio-welcome Consulting CO., LTD has collaborated with other pharmaceutical companies to establish the Chinese Medicine Registration Technology Alliance (CMRTA).